Uploaded byearningsreport
275 views
Johnson & Johnson 4q08 Wcweldon V10 Web
This presentation provides an overview and summary of Johnson & Johnson's 2008 business performance and outlook for 2009. Key points include: - J&J delivered strong financial results in 2008, meeting guidance targets for sales growth and adjusted earnings per share. - The company's three business segments - pharmaceuticals, medical devices & diagnostics, and consumer - all experienced sales growth in 2008. - J&J is advancing its pharmaceutical, medical device, and consumer product pipelines with numerous new product filings planned for 2009-2010. - While macroeconomic uncertainties may impact 2009 performance, J&J is well positioned due to its diversified business portfolio and continued investment in R&D and new product development.
